The orphan nuclear receptor SHP inhibits apoptosis during the monocytic differentiation by inducing p21WAF1

다국어 초록 (Multilingual Abstract)

Small heterodimer partner (SHP) is an atypical member of nuclear receptor superfamily that lacks a DNA-binding domain. In previous study, we showed that SHP, c-jun, p65 of NF-κB subunits, and p21WAF1 expression was increased during monocytic differentiaton with the exposure of human leukemia cells to a differentiation agent, PMA. In this study, c-Jun and p65 were shown to mediate the transcriptional activation of the SHP promoter. In addition, SHP induced the cell cycle regulatory protein levels and cooperatively increased an induction of p21WAF1 expression with p65. Furthermore, SHP protected differentiated cells from etoposide-induced cellular apoptosis through the induction and cytoplasmic sequestration of p21WAF1. Complex formation between SHP and p21WAF1 was demonstrated by means of coimmunoprecipitation.
These results suggest that SHP prolongs a cellular survival of differentiating monocytes through the transcriptional regulation of target genes of cell survival and differentiation.

참고문헌 (Reference)

1 Fritah A, "p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha" 25 : 2419-2430, 2005

2 Gorospe M, "p21(Waf1/Cip1) protects against p53- mediated apoptosis of human melanoma cells" 14 : 929-935, 1997

3 Pennington KN, "kinase-dependent chronic activation of NF-kappaB is necessary for p21(WAF1/Cip1) inhibition of differentiationinduced apoptosis of monocytes" 21 : 1930-1941, 2001

4 Park MJ, "Transcriptional repression of the gluconeogenic gene PEPCK by the orphan nuclear receptor SHP through inhibitory interaction with C/EBPalpha" 402 : 567-574, 2007

5 Nguyen HQ, "The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage" 72 : 197-209, 1993

6 Brendel C, "The small heterodimer partner interacts with the liver X receptor alpha and represses its transcriptional activity" 16 : 2065-2076, 2002

7 Szabo E, "The role of jun and fos gene family members in 12-O-tetradecanoylphorbol-13-acetate induced hemopoietic differentiation" 2 : 475-482, 1991

8 Migliaccio E, "The p66shc adaptor protein controls oxidative stress response and life span in mammals" 402 : 309-313, 1999

9 Kim YS, "The orphan nuclear receptor small heterodimer partner as a novel coregulator of nuclear factor-kappa b in oxidized low density lipoproteintreated macrophage cell line RAW 264.7" 276 : 33736-33740, 2001b

10 Johansson L, "The orphan nuclear receptor SHP utilizes conserved LXXLL-related motifs for interactions with ligand-activated estrogen receptors" 20 : 1124-1133, 2000

11 Choi YH, "The orphan nuclear receptor SHP is involved in monocytic differentiation, and its expression is increased by c-Jun" 76 : 1082-1088, 2004

12 Lee YK, "The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation:two mechanisms for repression" 20 : 187-195, 2000

13 Angel P, "The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1" 55 : 875-885, 1988

14 이영래, "TNF-α upregulates PTEN via NF-κB signaling pathways inhuman leukemic cells" 생화학분자생물학회 39 (39): 121-127, 2007

15 Scott EW, "Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages" 265 : 1573-1577, 1994

16 Cory S, "Regulation of lymphocyte survival by the bcl-2 gene family" 13 : 513-543, 1995

17 Larsson LG, "Phorbol ester-induced terminal differentiation is inhibited in human U-937 monoblastic cells expressing a v-myc oncogene" 85 : 2638-2642, 1988

18 Nerlov C, "PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors" 12 : 2403-2412, 1998

19 LaBaer J, "New functional activities for the p21 family of CDK inhibitors" 11 : 847-862, 1997

20 Yeo MG, "Negative cross-talk between Nur77 and small heterodimer partner and its role in apoptotic cell death of hepatoma cells" 19 : 950-963, 2005

21 Andres V, "Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis" 132 : 657-666, 1996

22 Kelly LM, "MafB is an inducer of monocytic differentiation" 19 : 1987-1997, 2000

23 Oberg F, "Macrophages and the cytokine network" 25 : 2044-2047, 1993

24 Sherman ML, "Kufe DW. Transcriptional and post-transcriptional regulation of c-jun expression during monocytic differentiation of human myeloid leukemic cells" 265 : 3320-3323, 1990

25 Sherr CJ, "Inhibitors of mammalian G1 cyclin-dependent kinases" 9 : 1149-1163, 1995

26 Steinman RA, "Induction of p21 (WAF-1/CIP1) during differentiation" 9 : 3389-3396, 1994

27 Jiang H, "Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53" 9 : 3397-3406, 1994

28 Borgius LJ, "Glucocorticoid signaling is perturbed by the atypical orphan receptor and corepressor SHP" 277 : 49761-49766, 2002

29 Polyak K, "Genetic determinants of p53-induced apoptosis and growth arrest" 10 : 1945-1952, 1996

30 Baeuerle PA, "Function and activation of NF-kappa B in the immune system" 12 : 141-179, 1994

31 Lubbert M, "Expression and regulation of myeloid-specific genes in normal and leukemic myeloid cells" 77 : 909-924, 1991

32 Wang Z, "Evidence of a functional role for the cyclin-dependent kinase inhibitor p21(WAF1/CIP1/MDA6) in the reciprocal regulation of PKC activator-induced apoptosis and differentation in human myelomonocytic leukemia cells" 244 : 105-116, 1998

33 Freytag SO, "Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1" 8 : 1614-1624, 1988

34 Lee YK, "Dual mechanisms for repression of the monomeric orphan receptor liver receptor homologous protein-1 by the orphan small heterodimer partner" 277 : 2463-2467, 2002

35 Sanyal S, "Differential regulation of the orphan nuclear receptor small heterodimer partner (SHP) gene promoter by orphan nuclear receptor ERR isoforms" 277 : 1739-1748, 2002

36 Tanaka H, "Cytoplasmic p21(Cip1/WAF1) regulates neurite remodeling by inhibiting Rho-kinase activity" 158 : 321-329, 2002

37 Halevy O, "Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD" 267 : 1018-1021, 1995

38 Kim DK, "Constitutive hyperexpression of p21(WAF1) in human U266 myeloma cells blocks the lethal signaling induced by oxidative stress but not by Fas" 289 : 34-38, 2001a

39 Henkel GW, "Commitment to the monocytic lineage occurs in the absence of the transcription factor PU.1" 93 : 2849-2858, 1999

40 Kim KJ, "Chemokine stromal cell-derived factor-1 induction by C/EBPbeta activation is associated with all-trans-retinoic acid-induced leukemic cell differentiation" 82 : 1332-1339, 2007

41 Gobinet J, "Characterization of the interaction between androgen receptor and a new transcriptional inhibitor, SHP" 40 : 15369-15377, 2001

42 Jang MK, "Ca2+/calmodulin-dependent protein kinase IV stimulates nuclear factor-kappa B transactivation via phosphorylation of the p65 subunit" 276 : 20005-20010, 2001

43 Asada M, "Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation" 18 : 1223-1234, 1999

44 Seol W, "An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors" 272 : 1336-1339, 1996

45 Dignam JD, "Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei" 11 : 1475-1489, 1983

46 Casini T, "A function of p21 during promyelocytic leukemia cell differentiation independent of CDK inhibition and cell cycle arrest" 18 : 3235-3243, 1999